NEW YORK, Oct 17 (Reuters) - Merck & Co. on Wednesday said U.S. regulators have approved use of its Januvia diabetes drug in new combinations with other treatments, but noted reports of serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback